ID: ALA5191456

Max Phase: Preclinical

Molecular Formula: C44H52FN7O8S

Molecular Weight: 858.01

Associated Items:

Representations

Canonical SMILES:  Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCNC(=O)c2c(C)[nH]c(/C=C3\C(=O)Nc4ccc(F)cc43)c2C)C(C)(C)C)cc1

Standard InChI:  InChI=1S/C44H52FN7O8S/c1-24-34(19-32-31-17-29(45)11-12-33(31)50-40(32)55)49-25(2)37(24)42(57)46-13-14-59-15-16-60-22-36(54)51-39(44(4,5)6)43(58)52-21-30(53)18-35(52)41(56)47-20-27-7-9-28(10-8-27)38-26(3)48-23-61-38/h7-12,17,19,23,30,35,39,49,53H,13-16,18,20-22H2,1-6H3,(H,46,57)(H,47,56)(H,50,55)(H,51,54)/b32-19-/t30-,35+,39-/m1/s1

Standard InChI Key:  FMCCDNIHVMLCTK-XHQJFUIVSA-N

Associated Targets(Human)

HL-60 67320 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

K562 73714 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A498 42825 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NCM460 247 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

VHL/GSPT1 10 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

VHL/FLT3 13 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

VHL/KIT 4 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 858.01Molecular Weight (Monoisotopic): 857.3582AlogP: 4.27#Rotatable Bonds: 16
Polar Surface Area: 204.08Molecular Species: NEUTRALHBA: 10HBD: 6
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.39CX Basic pKa: 2.65CX LogP: 2.47CX LogD: 2.47
Aromatic Rings: 4Heavy Atoms: 61QED Weighted: 0.07Np Likeness Score: -0.81

References

1. Zhai J, Li C, Sun B, Wang S, Cui Y, Gao Q, Sang F..  (2022)  Sunitinib-based Proteolysis Targeting Chimeras (PROTACs) reduced the protein levels of FLT-3 and c-KIT in leukemia cell lines.,  78  [PMID:36332882] [10.1016/j.bmcl.2022.129041]

Source